Clinical Trial Update: A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of SHR4640 in subjects with gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• SHR4640

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gout | Phase 3 | Status: COMPLETED